Here, combining single-cell RNA sequencing (scRNA-seq), multiple-parameter flow cytometric analysis, and tissue-derived microbiome sequencing from liver and intestinal samples, our study reveals the complete CD4+ T cell landscape and the microbial composition in liver and intestine of NAFLD and NASH patients. The gene discussed is CD4; the disease is metabolic dysfunction-associated steatohepatitis.